• 1. Exclusive self-aligned β-phase PVDF films with abnormal piezoelectric coefficient prepared via phase inversion?
  N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 5. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds

Introduction to 5-Bromo-3-methyl-2-nitropyridine (CAS No. 114042-02-3)

5-Bromo-3-methyl-2-nitropyridine, identified by its CAS number 114042-02-3, is a significant compound in the realm of chemical and pharmaceutical research. This heterocyclic aromatic molecule has garnered considerable attention due to its versatile applications in the synthesis of various bioactive molecules. The presence of both bromine and nitro substituents on the pyridine ring endows it with unique reactivity, making it a valuable intermediate in organic synthesis.

The structural features of 5-Bromo-3-methyl-2-nitropyridine include a bromo group at the 5-position and a methyl group at the 3-position of the pyridine core, with a nitro group located at the 2-position. This specific arrangement enhances its utility in constructing more complex chemical entities, particularly in medicinal chemistry. The bromine atom, being electron-withdrawing, influences the electronic properties of the ring, while the methyl group adds steric hindrance that can be exploited in designing specific interactions with biological targets.

In recent years, researchers have been exploring the potential of 5-Bromo-3-methyl-2-nitropyridine in developing novel therapeutic agents. Its incorporation into pharmacophores has shown promise in various therapeutic areas, including oncology, inflammation, and central nervous system disorders. The nitro group, for instance, can be reduced to an amine, providing a pathway to introduce polar functionalities that can enhance binding affinity to biological receptors.

One of the most compelling aspects of 5-Bromo-3-methyl-2-nitropyridine is its role as a building block in drug discovery. The compound's reactivity allows for facile functionalization at multiple sites, enabling chemists to tailor molecular structures with precision. This flexibility has been leveraged in the synthesis of kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The bromo substituent, in particular, serves as a handle for cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, facilitating the introduction of aryl or heteroaryl groups.

The pharmaceutical industry has also been keen on exploring derivatives of 5-Bromo-3-methyl-2-nitropyridine due to its potential as a scaffold for new drugs. Studies have demonstrated its utility in generating compounds with inhibitory activity against various enzymes and receptors. For example, modifications at the 3-position with different alkyl or aryl groups have led to molecules with enhanced selectivity and potency. These findings underscore the importance of this compound in medicinal chemistry and highlight its potential for further development.

Recent advances in computational chemistry have further enhanced the understanding of how 5-Bromo-3-methyl-2-nitropyridine can be utilized in drug design. Molecular modeling studies have revealed insights into its interactions with biological targets, providing a rational basis for designing more effective derivatives. These computational approaches complement traditional synthetic strategies and accelerate the discovery process.

The synthesis of 5-Bromo-3-methyl-2-nitropyridine itself is an intriguing challenge that has been addressed by several research groups. Various synthetic routes have been developed, each offering distinct advantages in terms of yield, purity, and scalability. These methods often involve multi-step sequences that require careful optimization to ensure high-quality intermediates and final products.

In conclusion, 5-Bromo-3-methyl-2-nitropyridine (CAS No. 114042-02-3) represents a cornerstone compound in modern chemical biology and drug discovery. Its unique structural features and reactivity make it an indispensable tool for researchers aiming to develop novel therapeutic agents. As our understanding of its properties continues to grow, so too will its applications across various fields of science and medicine.

• 39856-50-3(5-Bromo-2-nitropyridine)
• 8015-91-6(Cinnamon Bark Oil)
• 1807273-49-9(5-Bromo-2-nitronicotinic acid)
• 1225278-70-5(5-bromo-4-methyl-2-nitro-pyridine)
• 155790-02-6(Pyridine,3-bromo-5-methyl-2-nitro-)
• 65169-41-7(Pyridine,3,5-dimethyl-2-nitro-)
• 15936-06-8(3-(Bromomethyl)-2-nitropyridine)
• 18368-73-5(3-Methyl-2-nitropyridine)
• 1805181-60-5(3-Bromo-2-nitropyridine-5-methanol)
• 1805569-46-3(5-Bromo-2-nitronicotinonitrile)